Hayder Hussein
@h4yder
Followers
136
Following
204
Media
5
Statuses
178
RT @ParalympicsGB: And it's GOOOOOOOLD for Megan Richter! Oooh yes!!. What a morning for the Brits on the bridge. #ParalympicsGB 🥇#ParaTri….
0
163
0
RT @HaemTRIAL: Are you a clinician who sees patients with secondary polycythaemia?. Are you frustrated by the lack of an evidence base for….
0
5
0
RT @smbenlazar: Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for #AML #leusm |British Jour….
0
39
0
RT @BloodScientist: Chromatin patterns 🧵. [1] How many times have you heard phrases like:."Fine chromatin"."Dotted like with a pencil"."Smo….
0
32
0
RT @VidhyaMurthy1: Excellent presentation by Vaishali o risk factors and outcomes of CAR T manufacturing failure. #ASH2023 .
0
6
0
RT @PipNicolson: Very pleased to able to share our latest research on platelet activation in #VITT authored by @richardbuka and @sam_310 fr….
0
8
0
RT @harrisoncn1: Super pleased to see that NICE has approved Ruxolitinib for PV in England !! @MPNVoice FDG published today. Let’s get on a….
0
15
0
RT @VidhyaMurthy1: Our first regional AML day. Excellent talks and stimulating discussions.@UhbTeam @FWANDROO @HaemOnc @francescakinse3 @h4….
0
1
0
RT @Dr_AmerZeidan: Does this trial change your practice? Not for me as we were already giving GO with IC only for CBF-AML and not for non-C….
0
12
0
RT @AdamMead_Oxford: 🔥🔥🔥🔥🔥🔥 MAJIC study published in @JCO_ASCO . Ruxolitinib (rux) Versus Best Available Therapy (BAT) for Polycythemia Ver….
ascopubs.org
PURPOSEPolycythemia vera (PV) is characterized by JAK/STAT activation, thrombotic/hemorrhagic events, systemic symptoms, and disease transformation. In high-risk PV, ruxolitinib controls blood counts...
0
22
0
0
1
0
RT @HemeHillis: When should we move to second line in PV? According to @harrisoncn1 (subbing in for Dr Vannucchi) these are the recommendat….
0
1
0
RT @richardbuka: Haem trainee / junior doc / AHP - Please consider entering this year's @BritSocHaem's Crucible: 300 words on What Can Haem….
b-s-h.org.uk
In its second year, an innovative trainee-led initiative with a £1000 prize. The aim of this session is to encourage reflection on what we do as haematologists, and why we do it. The theme is "How...
0
7
0
RT @BHPComms: 🩸Dr Gillian Lowe - @uhbtrust haematology consultant and @unibirmingham senior lecturer - has been appointed National Haematol….
0
11
0
RT @WilsonAndrewDr: Good to see that our @BritSocHaem good practice paper on the management of older patients with frailty and acute myeloi….
onlinelibrary.wiley.com
Click on the article title to read more.
0
24
0
RT @PapaemmanuilLab: What is the risk conferred by my disease? One of the hardest questions to answer in medicine. A on the development of….
evidence.nejm.org
Risk stratification and therapeutic decision-making for myelodysplastic syndromes (MDS) are based on the International Prognostic Scoring System–Revised (IPSS-R), which considers hematologic parame...
0
158
0
0
46
0
RT @Steve1walker: 80yo F for general health check up. FBE: Hb 137 / WCC 13.6 / Plt 318 .Blood film (pictured). Diagnosis? Further tests? Tr….
0
26
0